| 0 |
POPLITEAL ARTERY ENTRAPMENT SYNDROME |
1 |
0.2000 |
| 1 |
LIP COSMETIC PROCEDURE |
1 |
0.1250 |
| 2 |
PHOTOREFRACTIVE KERATECTOMY |
1 |
0.0714 |
| 3 |
AQUAGENIC WRINKLING OF PALMS |
1 |
0.0500 |
| 4 |
ALCOHOL TEST POSITIVE |
1 |
0.0213 |
| 5 |
EYE ABRASION |
1 |
0.0189 |
| 6 |
AUTOPHONY |
1 |
0.0133 |
| 7 |
VERTEBROBASILAR ARTERY DISSECTION |
1 |
0.0114 |
| 8 |
LIPOMA EXCISION |
1 |
0.0093 |
| 9 |
CATHETER SITE DISCOLOURATION |
1 |
0.0082 |
| 10 |
DEVICE DEPENDENCE |
1 |
0.0064 |
| 11 |
DEAFNESS PERMANENT |
1 |
0.0051 |
| 12 |
DEVICE COMPUTER ISSUE |
1 |
0.0033 |
| 13 |
CENTRAL SLEEP APNOEA SYNDROME |
1 |
0.0031 |
| 14 |
DEPENDENCE ON RESPIRATOR |
1 |
0.0025 |
| 15 |
BLOOD URIC ACID ABNORMAL |
1 |
0.0025 |
| 16 |
TONGUE ERUPTION |
1 |
0.0020 |
| 17 |
PATELLOFEMORAL PAIN SYNDROME |
1 |
0.0019 |
| 18 |
INTERTRIGO |
1 |
0.0018 |
| 19 |
INFUSION RELATED HYPERSENSITIVITY REACTION |
1 |
0.0017 |
| 20 |
PALATAL DISORDER |
1 |
0.0017 |
| 21 |
ALLERGY TO METALS |
1 |
0.0016 |
| 22 |
INCREASED VISCOSITY OF BRONCHIAL SECRETION |
1 |
0.0016 |
| 23 |
SOCIAL ANXIETY DISORDER |
1 |
0.0015 |
| 24 |
MAST CELL ACTIVATION SYNDROME |
2 |
0.0014 |
| 25 |
TRAUMATIC FRACTURE |
1 |
0.0014 |
| 26 |
SMALL FIBRE NEUROPATHY |
1 |
0.0014 |
| 27 |
TRACHEITIS |
1 |
0.0013 |
| 28 |
COLONIC ABSCESS |
1 |
0.0012 |
| 29 |
DEVICE LOOSENING |
1 |
0.0012 |
| 30 |
ENDOCRINE OPHTHALMOPATHY |
1 |
0.0012 |
| 31 |
SKIN TEXTURE ABNORMAL |
1 |
0.0010 |
| 32 |
EYELID RASH |
1 |
0.0010 |
| 33 |
SKIN OEDEMA |
1 |
0.0010 |
| 34 |
PRODUCT NAME CONFUSION |
1 |
0.0009 |
| 35 |
PERIRECTAL ABSCESS |
1 |
0.0009 |
| 36 |
CATHETER SITE DISCHARGE |
1 |
0.0009 |
| 37 |
LUMBAR RADICULOPATHY |
1 |
0.0009 |
| 38 |
PULMONARY INFARCTION |
2 |
0.0008 |
| 39 |
BILE DUCT STENOSIS |
1 |
0.0008 |
| 40 |
CHRONIC RESPIRATORY FAILURE |
1 |
0.0008 |
| 41 |
XEROSIS |
1 |
0.0008 |
| 42 |
BLADDER DISCOMFORT |
1 |
0.0008 |
| 43 |
OVARIAN CYST RUPTURED |
1 |
0.0008 |
| 44 |
INFUSION SITE RASH |
1 |
0.0007 |
| 45 |
MYELITIS TRANSVERSE |
1 |
0.0007 |
| 46 |
OBSTRUCTIVE SLEEP APNOEA SYNDROME |
1 |
0.0007 |
| 47 |
GENERALISED ANXIETY DISORDER |
1 |
0.0007 |
| 48 |
PALLIATIVE CARE |
1 |
0.0007 |
| 49 |
TRANSCRIPTION MEDICATION ERROR |
1 |
0.0006 |
| 50 |
AORTIC VALVE DISEASE |
1 |
0.0006 |
| 51 |
TONGUE COATED |
1 |
0.0006 |
| 52 |
VERTIGO POSITIONAL |
1 |
0.0006 |
| 53 |
INFUSION SITE DISCHARGE |
1 |
0.0006 |
| 54 |
APPLICATION SITE DISCOMFORT |
1 |
0.0006 |
| 55 |
PNEUMOMEDIASTINUM |
1 |
0.0006 |
| 56 |
DIFFUSE ALOPECIA |
1 |
0.0005 |
| 57 |
PRODUCT ADMINISTRATION INTERRUPTED |
4 |
0.0005 |
| 58 |
REBOUND ATOPIC DERMATITIS |
1 |
0.0005 |
| 59 |
CHEST INJURY |
1 |
0.0005 |
| 60 |
PRE-EXISTING CONDITION IMPROVED |
3 |
0.0005 |
| 61 |
PERIARTHRITIS |
1 |
0.0004 |
| 62 |
DISTURBANCE IN SOCIAL BEHAVIOUR |
1 |
0.0004 |
| 63 |
PANNICULITIS |
1 |
0.0004 |
| 64 |
APPLICATION SITE BURN |
2 |
0.0004 |
| 65 |
ABNORMAL UTERINE BLEEDING |
1 |
0.0004 |
| 66 |
SKIN DISCOMFORT |
1 |
0.0004 |
| 67 |
SKIN WRINKLING |
1 |
0.0004 |
| 68 |
CLUMSINESS |
1 |
0.0004 |
| 69 |
NECK INJURY |
1 |
0.0003 |
| 70 |
CENTRAL VENOUS CATHETERISATION |
1 |
0.0003 |
| 71 |
INFUSION SITE PRURITUS |
1 |
0.0003 |
| 72 |
FACET JOINT SYNDROME |
1 |
0.0003 |
| 73 |
SKIN INJURY |
1 |
0.0003 |
| 74 |
MUSCLE CONTRACTIONS INVOLUNTARY |
1 |
0.0003 |
| 75 |
LOGORRHOEA |
1 |
0.0003 |
| 76 |
FACIAL PARESIS |
1 |
0.0003 |
| 77 |
MAJOR DEPRESSION |
2 |
0.0003 |
| 78 |
DERMATITIS CONTACT |
3 |
0.0003 |
| 79 |
PARANASAL SINUS HYPERSECRETION |
1 |
0.0003 |
| 80 |
OESOPHAGEAL ULCER |
1 |
0.0003 |
| 81 |
SOCIAL PROBLEM |
1 |
0.0002 |
| 82 |
SUICIDAL BEHAVIOUR |
1 |
0.0002 |
| 83 |
SELF-INJURIOUS IDEATION |
1 |
0.0002 |
| 84 |
INCORRECT DRUG ADMINISTRATION RATE |
1 |
0.0002 |
| 85 |
INTERVERTEBRAL DISC DISORDER |
1 |
0.0002 |
| 86 |
ALCOHOLISM |
1 |
0.0002 |
| 87 |
CHAPPED LIPS |
1 |
0.0002 |
| 88 |
ONYCHOMYCOSIS |
1 |
0.0002 |
| 89 |
RHINITIS ALLERGIC |
1 |
0.0002 |
| 90 |
IRON DEFICIENCY |
1 |
0.0002 |
| 91 |
EYE OPERATION |
1 |
0.0002 |
| 92 |
SYNOVIAL CYST |
1 |
0.0002 |
| 93 |
ENTEROCOCCAL INFECTION |
1 |
0.0002 |
| 94 |
HORMONE LEVEL ABNORMAL |
1 |
0.0002 |
| 95 |
DYSLIPIDAEMIA |
1 |
0.0002 |
| 96 |
INJECTION SITE DISCHARGE |
1 |
0.0002 |
| 97 |
CHEILITIS |
1 |
0.0002 |
| 98 |
INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS |
1 |
0.0002 |
| 99 |
SKIN INFECTION |
2 |
0.0002 |
| 100 |
URINE ODOUR ABNORMAL |
1 |
0.0002 |
| 101 |
DECREASED INTEREST |
1 |
0.0002 |
| 102 |
PIGMENTATION DISORDER |
1 |
0.0002 |
| 103 |
NASAL DRYNESS |
1 |
0.0002 |
| 104 |
EYE MOVEMENT DISORDER |
1 |
0.0001 |
| 105 |
DROOLING |
1 |
0.0001 |
| 106 |
THERMAL BURN |
1 |
0.0001 |
| 107 |
SENSITIVE SKIN |
1 |
0.0001 |
| 108 |
DRUG EFFECT LESS THAN EXPECTED |
2 |
0.0001 |
| 109 |
FEELING DRUNK |
1 |
0.0001 |
| 110 |
DERMATITIS ATOPIC |
7 |
0.0001 |
| 111 |
APNOEA |
1 |
0.0001 |
| 112 |
RENAL CYST |
1 |
0.0001 |
| 113 |
POST PROCEDURAL INFECTION |
1 |
0.0001 |
| 114 |
SHOCK HAEMORRHAGIC |
1 |
0.0001 |
| 115 |
DECUBITUS ULCER |
1 |
0.0001 |
| 116 |
POLYURIA |
1 |
0.0001 |
| 117 |
SPINAL COMPRESSION FRACTURE |
1 |
0.0001 |
| 118 |
INFUSION SITE ERYTHEMA |
1 |
0.0001 |
| 119 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
2 |
0.0001 |
| 120 |
FACIAL PARALYSIS |
1 |
0.0001 |
| 121 |
SKIN HYPERPIGMENTATION |
1 |
0.0001 |
| 122 |
IMMUNOSUPPRESSION |
1 |
0.0001 |
| 123 |
FLANK PAIN |
1 |
0.0001 |
| 124 |
ARTERIOSCLEROSIS |
1 |
0.0001 |
| 125 |
SPINAL DISORDER |
1 |
0.0001 |
| 126 |
INTENTIONAL DOSE OMISSION |
3 |
0.0001 |
| 127 |
INCREASED APPETITE |
2 |
0.0001 |
| 128 |
COELIAC DISEASE |
1 |
0.0001 |
| 129 |
PERITONITIS BACTERIAL |
1 |
0.0001 |
| 130 |
DISCOMFORT |
6 |
0.0001 |
| 131 |
INITIAL INSOMNIA |
1 |
0.0001 |
| 132 |
PRODUCT ODOUR ABNORMAL |
1 |
0.0001 |
| 133 |
JOINT DISLOCATION |
1 |
0.0001 |
| 134 |
RENAL PAIN |
1 |
0.0001 |
| 135 |
HYPOTHYROIDISM |
3 |
0.0001 |
| 136 |
POOR QUALITY SLEEP |
2 |
0.0001 |
| 137 |
SKIN LACERATION |
1 |
0.0001 |
| 138 |
PULMONARY THROMBOSIS |
1 |
0.0001 |
| 139 |
OESOPHAGITIS |
1 |
0.0001 |
| 140 |
THERAPY NON-RESPONDER |
4 |
0.0001 |
| 141 |
BACTERAEMIA |
1 |
0.0001 |
| 142 |
WRIST FRACTURE |
1 |
0.0001 |
| 143 |
THYROID CANCER |
1 |
0.0001 |
| 144 |
BURSITIS |
1 |
0.0001 |
| 145 |
FIBROMYALGIA |
2 |
0.0001 |
| 146 |
MUSCLE SPASTICITY |
1 |
0.0001 |
| 147 |
SPINAL OPERATION |
1 |
0.0001 |
| 148 |
ANHEDONIA |
2 |
0.0001 |
| 149 |
TOOTH INFECTION |
1 |
0.0001 |
| 150 |
EAR INFECTION |
2 |
0.0001 |
| 151 |
QUALITY OF LIFE DECREASED |
1 |
0.0001 |
| 152 |
LIMB INJURY |
2 |
0.0001 |
| 153 |
IMPAIRED GASTRIC EMPTYING |
1 |
0.0001 |
| 154 |
APPLICATION SITE RASH |
1 |
0.0001 |
| 155 |
HUNGER |
1 |
0.0001 |
| 156 |
MASS |
1 |
0.0001 |
| 157 |
PRODUCT DOSE OMISSION IN ERROR |
2 |
0.0001 |
| 158 |
IMPAIRED QUALITY OF LIFE |
1 |
0.0001 |
| 159 |
HYPOKINESIA |
1 |
0.0001 |
| 160 |
COMPLICATION ASSOCIATED WITH DEVICE |
1 |
0.0001 |
| 161 |
SURGERY |
4 |
0.0001 |
| 162 |
PULMONARY MASS |
1 |
0.0001 |
| 163 |
EJECTION FRACTION DECREASED |
1 |
0.0001 |
| 164 |
ACUTE MYELOID LEUKAEMIA |
1 |
0.0001 |
| 165 |
THERAPY PARTIAL RESPONDER |
1 |
0.0001 |
| 166 |
BASAL CELL CARCINOMA |
1 |
0.0001 |
| 167 |
PRODUCT USE COMPLAINT |
1 |
0.0001 |
| 168 |
OBESITY |
1 |
0.0001 |
| 169 |
SENSORY DISTURBANCE |
1 |
0.0001 |
| 170 |
BLOOD POTASSIUM INCREASED |
1 |
0.0001 |
| 171 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
1 |
0.0001 |
| 172 |
GALLBLADDER DISORDER |
1 |
0.0001 |
| 173 |
THIRST |
1 |
0.0001 |
| 174 |
RASH PRURITIC |
3 |
0.0001 |
| 175 |
HYPERHIDROSIS |
7 |
0.0001 |
| 176 |
MIDDLE INSOMNIA |
1 |
0.0001 |
| 177 |
HEPATIC CIRRHOSIS |
1 |
0.0001 |
| 178 |
FOOT FRACTURE |
1 |
0.0001 |
| 179 |
GASTRIC ULCER |
1 |
0.0001 |
| 180 |
SLEEP APNOEA SYNDROME |
1 |
0.0001 |
| 181 |
MIGRAINE |
5 |
0.0001 |
| 182 |
SINUS DISORDER |
1 |
0.0001 |
| 183 |
UPPER LIMB FRACTURE |
1 |
0.0001 |
| 184 |
SPINAL FRACTURE |
1 |
0.0000 |
| 185 |
FULL BLOOD COUNT DECREASED |
1 |
0.0000 |
| 186 |
PRODUCT ADMINISTRATION ERROR |
1 |
0.0000 |
| 187 |
PRODUCT PREPARATION ERROR |
1 |
0.0000 |
| 188 |
TREATMENT FAILURE |
4 |
0.0000 |
| 189 |
DERMATITIS |
1 |
0.0000 |
| 190 |
IRRITABLE BOWEL SYNDROME |
1 |
0.0000 |
| 191 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
1 |
0.0000 |
| 192 |
SKIN IRRITATION |
2 |
0.0000 |
| 193 |
NEPHROLITHIASIS |
2 |
0.0000 |
| 194 |
MUSCLE TWITCHING |
1 |
0.0000 |
| 195 |
SLEEP DISORDER |
3 |
0.0000 |
| 196 |
BLOOD PRESSURE FLUCTUATION |
1 |
0.0000 |
| 197 |
NEURALGIA |
1 |
0.0000 |
| 198 |
INJECTION SITE URTICARIA |
1 |
0.0000 |
| 199 |
EPISTAXIS |
3 |
0.0000 |
| 200 |
PNEUMONIA ASPIRATION |
1 |
0.0000 |
| 201 |
CELLULITIS |
2 |
0.0000 |
| 202 |
HAEMATEMESIS |
1 |
0.0000 |
| 203 |
SKIN ULCER |
1 |
0.0000 |
| 204 |
ECZEMA |
2 |
0.0000 |
| 205 |
MUCOSAL INFLAMMATION |
1 |
0.0000 |
| 206 |
JOINT STIFFNESS |
1 |
0.0000 |
| 207 |
PAIN OF SKIN |
1 |
0.0000 |
| 208 |
OEDEMA |
2 |
0.0000 |
| 209 |
SKIN LESION |
1 |
0.0000 |
| 210 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
2 |
0.0000 |
| 211 |
ABNORMAL DREAMS |
1 |
0.0000 |
| 212 |
NECK PAIN |
2 |
0.0000 |
| 213 |
NEEDLE ISSUE |
1 |
0.0000 |
| 214 |
LABORATORY TEST ABNORMAL |
1 |
0.0000 |
| 215 |
EMOTIONAL DISTRESS |
4 |
0.0000 |
| 216 |
CONTRAINDICATED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 217 |
INJECTION SITE RASH |
1 |
0.0000 |
| 218 |
FEMUR FRACTURE |
1 |
0.0000 |
| 219 |
BONE DENSITY DECREASED |
1 |
0.0000 |
| 220 |
HEAD INJURY |
1 |
0.0000 |
| 221 |
PULMONARY EMBOLISM |
3 |
0.0000 |
| 222 |
NIGHT SWEATS |
1 |
0.0000 |
| 223 |
PRODUCT DOSE OMISSION ISSUE |
9 |
0.0000 |
| 224 |
CHOLELITHIASIS |
1 |
0.0000 |
| 225 |
THERAPEUTIC RESPONSE SHORTENED |
1 |
0.0000 |
| 226 |
URINARY RETENTION |
1 |
0.0000 |
| 227 |
GAIT INABILITY |
1 |
0.0000 |
| 228 |
TRANSIENT ISCHAEMIC ATTACK |
1 |
0.0000 |
| 229 |
ANGER |
1 |
0.0000 |
| 230 |
NIGHTMARE |
1 |
0.0000 |
| 231 |
RASH |
12 |
0.0000 |
| 232 |
ACCIDENTAL OVERDOSE |
1 |
0.0000 |
| 233 |
RESTLESSNESS |
1 |
0.0000 |
| 234 |
DYSURIA |
1 |
0.0000 |
| 235 |
SEPSIS |
3 |
0.0000 |
| 236 |
EYE SWELLING |
1 |
0.0000 |
| 237 |
COLITIS |
1 |
0.0000 |
| 238 |
ACNE |
2 |
0.0000 |
| 239 |
INJECTION SITE SWELLING |
2 |
0.0000 |
| 240 |
SEIZURE |
3 |
0.0000 |
| 241 |
INJECTION SITE BRUISING |
2 |
0.0000 |
| 242 |
JOINT SWELLING |
3 |
0.0000 |
| 243 |
GASTROOESOPHAGEAL REFLUX DISEASE |
2 |
0.0000 |
| 244 |
EXTRA DOSE ADMINISTERED |
1 |
0.0000 |
| 245 |
ANXIETY |
7 |
0.0000 |
| 246 |
LUNG NEOPLASM MALIGNANT |
1 |
0.0000 |
| 247 |
OSTEOPOROSIS |
1 |
0.0000 |
| 248 |
INJECTION SITE ERYTHEMA |
3 |
0.0000 |
| 249 |
WITHDRAWAL SYNDROME |
1 |
0.0000 |
| 250 |
OSTEOARTHRITIS |
1 |
0.0000 |
| 251 |
DEVICE DISLOCATION |
1 |
0.0000 |
| 252 |
INTENTIONAL PRODUCT USE ISSUE |
2 |
0.0000 |
| 253 |
LIVER DISORDER |
1 |
0.0000 |
| 254 |
COLITIS ULCERATIVE |
1 |
0.0000 |
| 255 |
TINNITUS |
1 |
0.0000 |
| 256 |
SKIN DISCOLOURATION |
1 |
0.0000 |
| 257 |
UPPER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 258 |
HYPERSENSITIVITY |
4 |
0.0000 |
| 259 |
BLOOD CHOLESTEROL INCREASED |
1 |
0.0000 |
| 260 |
COGNITIVE DISORDER |
1 |
0.0000 |
| 261 |
WRONG TECHNIQUE IN DEVICE USAGE PROCESS |
1 |
0.0000 |
| 262 |
PRODUCTIVE COUGH |
1 |
0.0000 |
| 263 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
1 |
0.0000 |
| 264 |
CONTUSION |
2 |
0.0000 |
| 265 |
INFECTION |
3 |
0.0000 |
| 266 |
FLUSHING |
2 |
0.0000 |
| 267 |
FLUID RETENTION |
1 |
0.0000 |
| 268 |
CHEST DISCOMFORT |
2 |
0.0000 |
| 269 |
SINUSITIS |
2 |
0.0000 |
| 270 |
ERYTHEMA |
4 |
0.0000 |
| 271 |
ILLNESS |
2 |
0.0000 |
| 272 |
HYPERTENSION |
4 |
0.0000 |
| 273 |
DRUG EFFECT DECREASED |
1 |
0.0000 |
| 274 |
CONSTIPATION |
4 |
0.0000 |
| 275 |
TREATMENT NONCOMPLIANCE |
1 |
0.0000 |
| 276 |
PRURITUS |
7 |
0.0000 |
| 277 |
FALL |
6 |
0.0000 |
| 278 |
ARTHROPATHY |
1 |
0.0000 |
| 279 |
WEIGHT DECREASED |
5 |
0.0000 |
| 280 |
URTICARIA |
3 |
0.0000 |
| 281 |
ABDOMINAL DISCOMFORT |
3 |
0.0000 |
| 282 |
HYPONATRAEMIA |
1 |
0.0000 |
| 283 |
MYALGIA |
3 |
0.0000 |
| 284 |
FLATULENCE |
1 |
0.0000 |
| 285 |
URINARY TRACT INFECTION |
3 |
0.0000 |
| 286 |
DEPRESSION |
4 |
0.0000 |
| 287 |
HERPES ZOSTER |
1 |
0.0000 |
| 288 |
LETHARGY |
1 |
0.0000 |
| 289 |
BACK PAIN |
4 |
0.0000 |
| 290 |
COVID-19 |
3 |
0.0000 |
| 291 |
BONE PAIN |
1 |
0.0000 |
| 292 |
CHILLS |
2 |
0.0000 |
| 293 |
NASAL CONGESTION |
1 |
0.0000 |
| 294 |
IRRITABILITY |
1 |
0.0000 |
| 295 |
ILL-DEFINED DISORDER |
1 |
0.0000 |
| 296 |
PRODUCT USE IN UNAPPROVED INDICATION |
4 |
0.0000 |
| 297 |
EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 298 |
HEADACHE |
10 |
0.0000 |
| 299 |
DEVICE EXPULSION |
1 |
0.0000 |
| 300 |
SWELLING FACE |
1 |
0.0000 |
| 301 |
BLOOD CREATININE INCREASED |
1 |
0.0000 |
| 302 |
INFUSION RELATED REACTION |
1 |
0.0000 |
| 303 |
FEBRILE NEUTROPENIA |
1 |
0.0000 |
| 304 |
DRY SKIN |
2 |
0.0000 |
| 305 |
INJECTION SITE PRURITUS |
1 |
0.0000 |
| 306 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
3 |
0.0000 |
| 307 |
HEPATIC ENZYME INCREASED |
1 |
0.0000 |
| 308 |
PAIN |
9 |
0.0000 |
| 309 |
MEMORY IMPAIRMENT |
2 |
0.0000 |
| 310 |
COUGH |
4 |
0.0000 |
| 311 |
BURNING SENSATION |
1 |
0.0000 |
| 312 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
1 |
0.0000 |
| 313 |
THERAPY INTERRUPTED |
1 |
0.0000 |
| 314 |
MOBILITY DECREASED |
1 |
0.0000 |
| 315 |
UNDERDOSE |
1 |
0.0000 |
| 316 |
PAIN IN EXTREMITY |
4 |
0.0000 |
| 317 |
HYPOAESTHESIA |
2 |
0.0000 |
| 318 |
HOT FLUSH |
1 |
0.0000 |
| 319 |
UNEVALUABLE EVENT |
1 |
0.0000 |
| 320 |
CHRONIC KIDNEY DISEASE |
1 |
0.0000 |
| 321 |
CONDITION AGGRAVATED |
4 |
0.0000 |
| 322 |
INJECTION SITE PAIN |
4 |
0.0000 |
| 323 |
HOSPITALISATION |
2 |
0.0000 |
| 324 |
PERIPHERAL SWELLING |
2 |
0.0000 |
| 325 |
DRUG DOSE OMISSION BY DEVICE |
1 |
0.0000 |
| 326 |
ARTHRITIS |
1 |
0.0000 |
| 327 |
PARAESTHESIA |
2 |
0.0000 |
| 328 |
CARDIAC FAILURE CONGESTIVE |
1 |
0.0000 |
| 329 |
THROMBOSIS |
1 |
0.0000 |
| 330 |
DRY MOUTH |
1 |
0.0000 |
| 331 |
INFLUENZA LIKE ILLNESS |
1 |
0.0000 |
| 332 |
ARTHRALGIA |
5 |
0.0000 |
| 333 |
RENAL IMPAIRMENT |
1 |
0.0000 |
| 334 |
SKIN EXFOLIATION |
1 |
0.0000 |
| 335 |
PYREXIA |
4 |
0.0000 |
| 336 |
MUSCULOSKELETAL STIFFNESS |
1 |
0.0000 |
| 337 |
DRUG INEFFECTIVE |
15 |
0.0000 |
| 338 |
INSOMNIA |
3 |
0.0000 |
| 339 |
GASTROINTESTINAL DISORDER |
1 |
0.0000 |
| 340 |
ADVERSE DRUG REACTION |
1 |
0.0000 |
| 341 |
NO ADVERSE EVENT |
2 |
0.0000 |
| 342 |
MUSCLE SPASMS |
2 |
0.0000 |
| 343 |
OROPHARYNGEAL PAIN |
1 |
0.0000 |
| 344 |
CARDIAC DISORDER |
1 |
0.0000 |
| 345 |
SWELLING |
1 |
0.0000 |
| 346 |
PRODUCT USE ISSUE |
2 |
0.0000 |
| 347 |
VOMITING |
5 |
0.0000 |
| 348 |
DYSPHAGIA |
1 |
0.0000 |
| 349 |
DRUG INTOLERANCE |
1 |
0.0000 |
| 350 |
FATIGUE |
8 |
0.0000 |
| 351 |
ALOPECIA |
2 |
0.0000 |
| 352 |
NAUSEA |
8 |
0.0000 |
| 353 |
DIZZINESS |
5 |
0.0000 |
| 354 |
SYNCOPE |
1 |
0.0000 |
| 355 |
DIARRHOEA |
6 |
0.0000 |
| 356 |
WHITE BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 357 |
OFF LABEL USE |
8 |
0.0000 |
| 358 |
THROMBOCYTOPENIA |
1 |
0.0000 |
| 359 |
WEIGHT INCREASED |
2 |
0.0000 |
| 360 |
MUSCULAR WEAKNESS |
1 |
0.0000 |
| 361 |
DECREASED APPETITE |
2 |
0.0000 |
| 362 |
DISEASE PROGRESSION |
1 |
0.0000 |
| 363 |
FEELING ABNORMAL |
2 |
0.0000 |
| 364 |
OEDEMA PERIPHERAL |
1 |
0.0000 |
| 365 |
PSORIASIS |
1 |
0.0000 |
| 366 |
DEHYDRATION |
1 |
0.0000 |
| 367 |
VISION BLURRED |
1 |
0.0000 |
| 368 |
BLOOD PRESSURE INCREASED |
1 |
0.0000 |
| 369 |
ACUTE KIDNEY INJURY |
1 |
0.0000 |
| 370 |
TREMOR |
1 |
0.0000 |
| 371 |
CEREBROVASCULAR ACCIDENT |
1 |
0.0000 |
| 372 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
1 |
0.0000 |
| 373 |
CHEST PAIN |
1 |
0.0000 |
| 374 |
DYSPNOEA |
3 |
0.0000 |
| 375 |
GAIT DISTURBANCE |
1 |
0.0000 |
| 376 |
HYPOTENSION |
1 |
0.0000 |
| 377 |
ABDOMINAL PAIN UPPER |
1 |
0.0000 |
| 378 |
ABDOMINAL PAIN |
1 |
0.0000 |
| 379 |
ASTHENIA |
1 |
0.0000 |
| 380 |
MALAISE |
1 |
0.0000 |
| 381 |
DEATH |
1 |
0.0000 |